FALSE000153743500015374352023-07-242023-07-24


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________
 
FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): December 12, 2023

Clean Energy Solutions Logo.jpg
TECOGEN INC. (OTCQX: TGEN)
(Exact Name of Registrant as Specified in Charter)

Delaware
(State or Other Jurisdiction of Incorporation)
001-36103 04-3536131
(Commission File Number) (IRS Employer Identification No.)
   
45 First Avenue  
Waltham, Massachusetts
 02451
(Address of Principal Executive Offices) (Zip Code)
(781) 466-6400
(Registrant's telephone number, including area code)
_______________________________________________
 
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each classTrading SymbolName of exchange on which registered
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

The Board of Directors of Tecogen Inc. is deeply saddened to announce that, on December 12, 2023, it was informed of the death, on December 9, 2023, of Mr. Fred Holubow, a director of the company and a member of the board’s Audit Committee since June 2020.

Until his death, Mr. Holubow served as a General Partner of Starbow Partners, an investor in early-stage healthcare ventures. From 2001 to December 2011, Mr. Holubow served as a Managing Director of William Harris Investors, Inc., a registered investment advisory firm, and from 1982 to 2001 he served as Vice President of Pegasus Associates, a registered investment advisory firm he co-founded.

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
TECOGEN INC.
By: /s/ Abinand Rangesh
December 14, 2023Abinand Rangesh, Chief Executive Officer

v3.23.3
Cover
Jul. 24, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 12, 2023
Entity Registrant Name TECOGEN INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-36103
Entity Tax Identification Number 04-3536131
Entity Address, Address Line One 45 First Avenue
Entity Address, State or Province MA
Entity Address, City or Town Waltham
Entity Address, Postal Zip Code 02451
City Area Code 781
Local Phone Number 466-6400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001537435
Tecogen (QX) (USOTC:TGEN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Tecogen (QX)
Tecogen (QX) (USOTC:TGEN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Tecogen (QX)